Tom Rossetti (Drs. Buck and Levin lab) was awarded an F31 fellowship from NIH (NIA). The title of his proposal is "Activation of Soluble Adenylyl Cyclase as a Novel Therapeutic Strategy for the Treatment of Age-Related Neurodegenerative Disorders.”
https://pharmacology.weill.cornell.edu/students/student-awards
